Sat.Jun 29, 2024 - Fri.Jul 05, 2024

article thumbnail

Is LTC Pharmacy Going Back to the Future?

Drug Topics

Drug Topics sat down with Sandra Canally, RN, founder and CEO of The Compliance Team, and Kara Benson, PharmD, long-term care director of Lewis Drug Inc, to discuss the future of LTC pharmacy.

211
211
article thumbnail

‘Visionary’ study finds inflammation, evidence of Covid virus years after infection

STAT

Remember when we thought Covid was a two-week illness? So does Michael Peluso, assistant professor of medicine at the University of California, San Francisco.  He recalls the rush to study acute Covid infection, and the crush of resulting papers. But Peluso, an HIV researcher, knew what his team excelled at: following people over the long term.

145
145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Babies of Mothers Prescribed GLP-1s Prior to Pregnancy May Have Increased Risk of NICU Stays

Pharmacy Times

Additionally, birth weight was higher in babies born to mothers who were prescribed glucagon-like peptide-1 (GLP-1) medications either 90 days prior to pregnancy or during the first trimester.

132
132
article thumbnail

Digital primary care startup K Health raises $50M in equity funding round

Fierce Healthcare

Digital primary care startup K Health raised $50 million in an equity funding round to build out its AI-powered medical services and fuel its growth, the company announced Monday. | Digital primary care startup K Health raised $50 million in an equity funding round to build out its AI-powered medical services and fuel its growth, the company announced Monday.

135
135
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

HHS Awards Moderna $176 Million to Develop Pandemic-Ready Influenza Vaccine

Drug Topics

“Adding this technology to our pandemic flu toolkit enhances our ability to be nimble and quick against the circulating strains and their potential variants,” said Dawn O’Connell, assistant secretary for preparedness and response at the HSS.

Vaccines 201
article thumbnail

CDC looks to expand capacity to test for H5N1 bird flu in people

STAT

As the H5N1 bird flu outbreak in dairy cows enters its fourth month, the Centers for Disease Control and Prevention is taking steps to ramp up the nation’s capacity to test for the virus in people. In a call with reporters Tuesday, Nirav Shah, the CDC’s principal deputy director, emphasized that the risk to the general public remains low at this time.

145
145

More Trending

article thumbnail

California is funding managed care plans to bring mental healthcare to schools. Here's how it's going

Fierce Healthcare

To address behavioral health access barriers for students, California launched a program to offer incentive payments to Medi-Cal managed care plans to build capacity for behavioral health services in K-12 schools.

135
135
article thumbnail

Mediterranean, DASH Diets May Lower Risk of Cardiovascular Disease in Patients with T1D

Drug Topics

Individuals who ate diets that aligned closer to DASH and Mediterranean guidelines had lower levels of plasminogen activator inhibitor-1 and homocysteine biomarkers.

196
196
article thumbnail

Study links Ozempic to higher risk of eye condition that can cause vision loss

STAT

A new observational study on Wednesday reported for the first time a potential link between Novo Nordisk’s GLP-1 drugs Ozempic and Wegovy and an eye condition that can cause vision loss. After hearing anecdotes of patients on the diabetes and obesity drugs experiencing nonarteritic anterior ischemic optic neuropathy, or NAION, researchers at Massachusetts Eye and Ear analyzed data from a registry of patients at their institution to see if there was a broad trend.

144
144
article thumbnail

FDA Approves Donanemab-Azbt for Early Symptomatic Alzheimer Disease

Pharmacy Times

Donanemab-azbt is the first and only amyloid plaque targeting therapy that supports stopping therapy when the plaque is removed.

FDA 139
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Steward Health Care spent millions spying on critics amid failing finances: report

Fierce Healthcare

As its stack of unpaid vendor obligations climbed, now-bankrupt Steward Health Care paid private investigators millions of dollars to follow and uncover compromising information on individuals | An investigative report details a "spare no expenses mission" in which executives authorized intelligence firms to allegedly follow, data mine and disseminate damaging information about individuals viewed as opponents.

135
135
article thumbnail

Continuous Glucose Monitors Help Reduce A1c in Patients with Diabetes

Drug Topics

Research presented at the American Diabetes Association 84th Scientific Sessions suggests a population approach to CGM use could be beneficial.

212
212
article thumbnail

As bird flu spreads among U.S. cattle, veterinarians find themselves in a familiar position: the frontlines

STAT

When, in April, the federal government began requiring some cows to be tested for a strain of avian flu before their herds could be moved across state lines, it seemed like an obvious step to try to track and slow the virus that had started spreading among U.S. dairy cattle. But Joe Armstrong, a veterinarian at the University of Minnesota extension school, feared the U.S.

143
143
article thumbnail

Changing Faces: Digital and supplier hires from April 2024

pharmaphorum

Changing Faces explores the digital and supplier hires from April 2024, with a focus on companies like SPT Labtech, Sphere Fluidics, Newel Health, and Diaceutics. Stay updated on the latest developments in the industry.

120
120
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Here's why a proposal for prior authorization CPT codes returned to the drawing board

Fierce Healthcare

A recent proposal to report prior authorization to insurance plans through CPT codes was withdrawn at the eleventh hour when its physician advocate made an unexpected discovery: For certain codes a | The advocate for a plan to reimburse physicians for time spent on rigorous claims learned that six CPT codes already include language about prior authorization.

Insurance 130
article thumbnail

GLP-1 Use and Risk of Cardiovascular Events in Different Patient Populations

Drug Topics

Three posters presented at the American Diabetes Association 84th Scientific Sessions examined GLP-1 use and cardiovascular disease risk in several different patient populations.

112
112
article thumbnail

Bird flu snapshot: A pathologist sees familiar echoes in U.S. response to the outbreak

STAT

Bird flu snapshot: This is the latest installment in a series of regular updates on H5N1 avian flu that STAT is publishing on Monday mornings. To read future updates you can also subscribe to STAT’s Morning Rounds newsletter. When pathologist Thijs Kuiken looks at what’s happening in the U.S. response to the H5N1 bird flu outbreak in dairy cows, he’s reminded of a difficult period in the Netherlands, where he lives, back in the late aughts.

144
144
article thumbnail

ASCO 2024: Emphasising the art and science behind enhanced cancer care

pharmaphorum

ASCO 2024 conference highlights the latest advancements in oncology, emphasising the art and science behind enhanced cancer care. Stay updated on the latest research, treatments, and innovations in the field of oncology.

118
118
article thumbnail

DOJ slaps $20M opioid prescription penalty on OptumRx

Fierce Healthcare

OptumRx will pay $20 million to resolve claims the company violated the Controlled Substances Act by improperly filling certain opioid prescriptions, the Department of Justice recently announced.

article thumbnail

Small Doses: June 24 to June 28

Drug Topics

Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.

152
152
article thumbnail

STAT+: GLP-1s lower risk of 10 obesity-associated cancers, study shows

STAT

New research finds that the GLP-1 class of drugs — glucagon-like peptide receptor agonists — is more effective in mitigating the risk of 10 obesity-associated cancers than its type 2 diabetes drug alternatives. The retrospective study, published Friday in JAMA Network Open , measured results for a cohort of more than 1.6 million patients with type 2 diabetes from 2005 to 2018 who were prescribed GLP-1s, insulin, or metformin.

141
141
article thumbnail

The power and potential of regenerative medicine

pharmaphorum

The field of muscle stem cell research has been tangibly developing over the decades and in today’s pharmaphorum podcast wed editor Nicole Raleigh speaks with Dr Michael Rudnicki, co-founder and CSO of Satellos Biosciences, a company dedicated to developing novel therapeutics based on this science for those who live with Duchenne muscular dystrophy (DMD) and other degenerative muscle diseases.

117
117
article thumbnail

As brick-and-mortar drugstores struggle, Amazon doubles down on revamping the pharmacy experience

Fierce Healthcare

LAS VEGAS—Amazon is betting big on its pharmacy arm, with the retail giant aiming to bring its focus on ease of use for consumers to the prescription drug space. | LAS VEGAS—Amazon is betting big on its pharmacy arm, with the retail giant aiming to bring its focus on ease of use for consumers to the prescription drug space.

125
125
article thumbnail

FDA Approves Donanemab (Kisunla) For Early Symptomatic Alzheimer Disease

Drug Topics

Donanemab-azbt was approved under the FDA's Fast Track Review, Priority Review, and Breakthrough Therapy designations.

FDA 123
article thumbnail

STAT+: Ascension is racing to unload hospitals as execs work to stem losses

STAT

For 15 years, a formidable CEO-CFO duo often called “the two Tonys” ushered their St. Louis-based health system through a period of explosive growth, adding hospital after hospital until it became one of the country’s biggest health systems. The year after former CEO Anthony Tersigni and former finance chief Anthony Speranzo stepped down, their sprawling empire of roughly 140 hospitals underwent the ultimate stress test: the Covid-19 pandemic.

Hospitals 141
article thumbnail

Innovation in generics: Increased efficiency through peptide API synthesis expertise

pharmaphorum

Discover how innovative approaches and specialised expertise in peptide API synthesis are increasing efficiency and driving advancements in the manufacturing of Active Pharmaceutical Ingredients (API).

116
116
article thumbnail

As Walmart shutters clinics, startup Fabric buys its MeMD telehealth business

Fierce Healthcare

As Walmart shutters its primary care clinics, the retail giant inked a deal to sell its MeMD telehealth business to healthcare technology startup Fabric. | The deal will significantly expand Fabric's reach in the employer market as MeMD provides virtual care services to 30,000 employers and 5 million employees.

125
125
article thumbnail

Community Pharmacies May Benefit From Embracing AI for Enhanced Profitability

Pharmacy Times

Artificial intelligence (AI) may optimize cash pricing strategies in community pharmacies.

article thumbnail

Opinion: Senate, FTC cracking down on pharma patent shenanigans

STAT

Why do Americans pay so much more for common medications than people in other countries? Why does an inhaler that costs $7 in France cost almost $500 in the United States? These are just a few of the questions the Senate Judiciary Committee looked to answer in a recent hearing. The common answer? Dominant corporations use a variety of patent-related strategies to protect their power, maximize their profits, and squash their competition.

article thumbnail

‘Accidental’ media switch leads to CAR T therapy discovery

European Pharmaceutical Review

Altering the conditions that T cells are grown in can improve CAR T-cell therapy, US researchers have found. Discovered by chance, their new method has potential to treat solid cancer tumours more efficiently, according to the findings. Putting T cells on a keto diet [putting our T cells on a three-day ‘keto’ diet] showed reduced maturity at the end of the manufacturing process.

116
116
article thumbnail

Legislation to grant 4-year coverage of breakthrough medical devices passes Ways and Means, with a heavy discount

Fierce Healthcare

The House Ways and Means Committee advanced bipartisan legislation on Thursday that would grant Medicare coverage to novel medical technologies for four years while the Centers for Medicare & M | The House Ways and Means Committee advanced updated legislation to expedite Medicare coverage of breakthrough medical devices. The new version of the bill reduces its cost by 75%, according to co-sponsor Rep.

125
125
article thumbnail

AstraZeneca files rival to Pemgarda for COVID PrEP

pharmaphorum

AstraZeneca may have exited the COVID-19 vaccine market, but it is still hoping to protect vulnerable patients with its antibody sipavibart for pre-exposure prophylaxis (PrEP).The drugmaker said this morning that an application for sipavibart (AZD3152) has been accepted for review by the EMA as PrEP for immunocompromised patients who often do not respond adequately to vaccination alone and remain at high risk of serious outcomes from COVID-19.

Vaccines 116
article thumbnail

Opinion: Psychiatrists aren’t fulfilling the social contract that subsidized their training

STAT

There has been much handwringing about how difficult it is for Americans with mental health issues to see a psychiatrist. Failures in the health insurance market are often blamed for the problem. As a new class of psychiatry residents begins work in hospitals across the country this week, I see an additional cause: the lack of commitment to honor the subsidies that made it possible for psychiatrists to enter the profession.

Insurance 134
article thumbnail

FDA Grants Marketing Authorization for Rapid Hepatitis C Test

Pharmacy Times

The test can be performed in settings that operate under the Clinical Laboratory Improvement Amendments waiver, including community pharmacies.